The authors used AAV viral vectors to edit via CRISPR-Cas9 specific regions of the gene responsible for the Duchenne muscular dystrophy and found that the treated muscles express dystrophin in up to 70% of the myogenic area and increased force [141]. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.